| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000026421 |
| Receipt No. | R000030353 |
| Official scientific title of the study | The effects of imidazole dipeptide supplementation on sleep and performance |
| Date of disclosure of the study information | 2017/03/06 |
| Last modified on | 2017/03/06 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The effects of imidazole dipeptide supplementation on sleep and performance | |
| Title of the study (Brief title) | The effects of imidazole dipeptide supplementation on sleep and performance | |
| Region |
|
|
| Condition | ||
| Condition | Healthy population | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | 1. To investigate the effects of imidazole dipeptide supplementation on sleep.
2. To investigate the effects of imidazole dipeptide supplementation on performance. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The present study is a balanced, randomized cross-over design with a 1-week intervening period.
We evaluate the following items at before and after intake of supplement. Objective sleep quality (i.e. sleep latency, sleep efficiency) Subjective sleep quality (questionnaire) athletic performance for badminton skill short service test (success rate) travelling time in badminton court |
| Key secondary outcomes | Test for attention performance
Go/No-go task Flexibility task |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of imidazole dipeptide supplementation
1week intervention 0.5g*3(before breakfast,lunch,dinner) 1.5g/day |
|
| Interventions/Control_2 | Intake of placebo
1week intervention 0.5g*3(before breakfast,lunch,dinner) 1.5g/day |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. BMI <28m2
2. 6 to 9 hours of sleep duration 3. Non smoker 4. They do not take excessive caffeine 5. Moderate morning or intermediate type |
|||
| Key exclusion criteria | 1. Sleeping hours differ for more than 45 minutes on weekdays and holidays
2. Turn off before 21 o'clock 3. Wake up after 9 o'clock |
|||
| Target sample size | 14 | |||
| Research contact person | |
| Name of lead principal investigator | Seiji Maeda |
| Organization | University of Tsukuba |
| Division name | Faculty of Health and Sport Sciences |
| Address | 1-1-1 Tennodai, Tsukuba |
| TEL | 029-853-8859 |
| maeda@taiiku.tsukuba.ac.jp | |
| Public contact | |
| Name of contact person | Yuki Nakamura |
| Organization | University of Tsukuba |
| Division name | Major of sport medicine |
| Address | 1-1-1 Tennodai, Tsukuba |
| TEL | 029-853-5600 |
| Homepage URL | |
| s1530397@u.tsukuba.ac.jp | |
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Tsukuba |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | NH Foods Ltd. |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030353 |